Welcome to BioSeeker Group!

Therapeutics

In this section you will find Therapeutics market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.

Items 1 to 150 of 621 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Ascending Direction
  1. Wnt Signaling Pathway in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 228 companies plus partners who are today developing 253 Wnt pathway targeting drugs in 935 developmental projects in cancer across 204 different targets. In addition, there are 2 suspended drugs and another 118 drugs where development has been ceased. Learn More

  2. Viral Carcinogenesis Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 246 companies plus partners who are today developing 311 viral carcinogenesis targeting drugs in 1170 developmental projects in cancer across 169 different targets. In addition, there is 1 suspended drug and another 138 drugs where development has been ceased. Learn More

  3. VEGF Signaling Pathway in Cancer Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 253 companies plus partners who are today developing 348 VEGF signaling pathway targeting drugs in 1433 developmental projects in cancer across 164 different targets. In addition, there are 3 suspended drugs and another 151 drugs where development has been ceased. Learn More

  4. Vascular Targeting Agents: Emerging Competitors

    $1,950.00
    Published by BioSeeker Group on Feb 8th, 2005
    An update on the most recent advances made for vascular targeting agents that are now entering an exciting stage of development. Learn More

  5. TSLP Signaling Pathway in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 248 companies plus partners who are today developing 306 TSLP pathway targeting drugs in 1255 developmental projects in cancer across 179 different targets. In addition, there are 2 suspended drugs and another 174 drugs where development has been ceased. Learn More

  6. TSH Signaling Pathway in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 226 companies plus partners who are today developing 315 TSH pathway targeting drugs in 1330 developmental projects in cancer across 183 different targets. In addition, there are 4 suspended drugs and another 150 drugs where development has been ceased. Learn More

  7. Triple Target Atlas in Oncology Drug Development

    $3,450.00
    Published by BioSeeker Group (Multi-report (See individual release dates))
    This report is an open landscape of resources to build, fuel, and drive your scientific competitive vehicle for the advancement of cancer drugs. It will assist you in lead commercial analysis and product strategy thinking to build and nurture current and future portfolio of drug candidates and R&D alliances. Learn More

  8. Triple Analysis: Protein Kinase Inhibitors, Antibodies and Peptides

    $3,450.00
    Published by BioSeeker Group on Jan 7th, 2013
    This triple analysis focuses on cancer drug development strategies by the mechanism/target/effect of Protein Kinase Inhibitors and by the two compound strategies of Antibodies and Peptides. Learn More

  9. Triple Analysis: Prostate Cancer, Protein Kinase Inhibitors and Peptides

    $3,450.00
    Published by BioSeeker Group on Jan 7th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Peptides). Learn More

  10. Triple Analysis: Prostate Cancer, Protein Kinase Inhibitors and Antibodies

    $3,450.00
    Published by BioSeeker Group on Nov 1st, 2012
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Antibodies). Learn More

  11. Triple Analysis: Prostate Cancer, Cancer Vaccines and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in Prostate Cancer and by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors. Learn More

  12. Triple Analysis: Prostate Cancer, Cancer Vaccines and Peptides

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Peptides). Learn More

  13. Triple Analysis: Prostate Cancer, Cancer Vaccines and Antibodies

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Antibodies). Learn More

  14. Triple Analysis: Prostate Cancer, Apoptosis and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on Sep 12th, 2012
    This triple analysis focuses on cancer drug development strategies in Prostate Cancer and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Learn More

  15. Triple Analysis: Prostate Cancer, Apoptosis and Peptides

    $3,450.00
    Published by BioSeeker Group on Jan 7th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Apoptosis) and one compound specific area (Peptides). Learn More

  16. Triple Analysis: Prostate Cancer, Apoptosis and Cancer Vaccines

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in Prostate Cancer and by the two mechanism/target/effect areas of Apoptosis and Cancer Vaccines. Learn More

  17. Triple Analysis: Prostate Cancer, Apoptosis and Antibodies

    $3,450.00
    Published by BioSeeker Group on Nov 1st, 2012
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Apoptosis) and one compound specific area (Antibodies). Learn More

  18. Triple Analysis: Prostate Cancer, Apoptosis and Angiogenesis

    $3,450.00
    Published by BioSeeker Group on Sep 12th, 2012
    This triple analysis focuses on cancer drug development strategies in Prostate Cancer and by the two mechanism/target/effect areas of Apoptosis and Angiogenesis. Learn More

  19. Triple Analysis: Prostate Cancer, Antibodies and Peptides

    $3,450.00
    Published by BioSeeker Group on Jan 7th, 2013
    This triple analysis focuses on cancer drug development strategies in Prostate Cancer and by the two compound strategies of Antibodies and Peptides. Learn More

  20. Triple Analysis: Prostate Cancer, Angiogenesis and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on Sep 12th, 2012
    This triple analysis focuses on cancer drug development strategies in Prostate Cancer and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Learn More

  21. Triple Analysis: Prostate Cancer, Angiogenesis and Peptides

    $3,450.00
    Published by BioSeeker Group on Jan 7th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Peptides). Learn More

  22. Triple Analysis: Prostate Cancer, Angiogenesis and Cancer Vaccines

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in Prostate Cancer and by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines. Learn More

  23. Triple Analysis: Prostate Cancer, Angiogenesis and Antibodies

    $3,450.00
    Published by BioSeeker Group on Nov 1st, 2012
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Antibodies). Learn More

  24. Triple Analysis: Pancreatic Cancer, Protein Kinase Inhibitors and Peptides

    $3,450.00
    Published by BioSeeker Group on Jan 7th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Pancreatic Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Peptides). Learn More

  25. Triple Analysis: Pancreatic Cancer, Protein Kinase Inhibitors and Antibodies

    $3,450.00
    Published by BioSeeker Group on Nov 1st, 2012
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Pancreatic Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Antibodies). Learn More

  26. Triple Analysis: Pancreatic Cancer, Prostate Cancer and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on Sep 12th, 2012
    This triple analysis focuses on cancer drug development strategies in both Pancreatic Cancer and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More

  27. Triple Analysis: Pancreatic Cancer, Prostate Cancer and Peptides

    $3,450.00
    Published by BioSeeker Group on Jan 7th, 2013
    This triple analysis focuses on cancer drug development strategies in both Pancreatic Cancer and Prostate Cancer and by the compound strategy of Peptides. Learn More

  28. Triple Analysis: Pancreatic Cancer, Prostate Cancer and Cancer Vaccines

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in both Pancreatic Cancer and Prostate Cancer and by the mechanism/target/effect of Cancer Vaccines. Learn More

  29. Triple Analysis: Pancreatic Cancer, Prostate Cancer and Apoptosis

    $3,450.00
    Published by BioSeeker Group on Sep 12th, 2012
    This triple analysis focuses on cancer drug development strategies in both Pancreatic Cancer and Prostate Cancer and by the mechanism/target/effect of Apoptosis. Learn More

  30. Triple Analysis: Pancreatic Cancer, Prostate Cancer and Antibodies

    $3,450.00
    Published by BioSeeker Group on Nov 1st, 2012
    This triple analysis focuses on cancer drug development strategies in both Pancreatic Cancer and Prostate Cancer and by the compound strategy of Antibodies. Learn More

  31. Triple Analysis: Pancreatic Cancer, Prostate Cancer and Angiogenesis

    $3,450.00
    Published by BioSeeker Group on Sep 12th, 2012
    This triple analysis focuses on cancer drug development strategies in both Pancreatic Cancer and Prostate Cancer and by the mechanism/target/effect of Angiogenesis. Learn More

  32. Triple Analysis: Pancreatic Cancer, Cancer Vaccines and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in Pancreatic Cancer and by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors. Learn More

  33. Triple Analysis: Pancreatic Cancer, Cancer Vaccines and Peptides

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Pancreatic Cancer), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Peptides). Learn More

  34. Triple Analysis: Pancreatic Cancer, Cancer Vaccines and Antibodies

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Pancreatic Cancer), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Antibodies). Learn More

  35. Triple Analysis: Pancreatic Cancer, Apoptosis and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on May 1st, 2012
    This triple analysis focuses on cancer drug development strategies in Pancreatic Cancer and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Learn More

  36. Triple Analysis: Pancreatic Cancer, Apoptosis and Peptides

    $3,450.00
    Published by BioSeeker Group on Jan 7th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Pancreatic Cancer), one mechanism/target/effect area (Apoptosis) and one compound specific area (Peptides). Learn More

  37. Triple Analysis: Pancreatic Cancer, Apoptosis and Cancer Vaccines

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in Pancreatic Cancer and by the two mechanism/target/effect areas of Apoptosis and Cancer Vaccines. Learn More

  38. Triple Analysis: Pancreatic Cancer, Apoptosis and Antibodies

    $3,450.00
    Published by BioSeeker Group on Nov 1st, 2012
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Pancreatic Cancer), one mechanism/target/effect area (Apoptosis) and one compound specific area (Antibodies). Learn More

  39. Triple Analysis: Pancreatic Cancer, Apoptosis and Angiogenesis

    $3,450.00
    Published by BioSeeker Group on Mar 1st, 2012
    This triple analysis focuses on cancer drug development strategies in Pancreatic Cancer and by the two mechanism/target/effect areas of Apoptosis and Angiogenesis. Learn More

  40. Triple Analysis: Pancreatic Cancer, Antibodies and Peptides

    $3,450.00
    Published by BioSeeker Group on Jan 7th, 2013
    This triple analysis focuses on cancer drug development strategies in Pancreatic Cancer and by the two compound strategies of Antibodies and Peptides. Learn More

  41. Triple Analysis: Pancreatic Cancer, Angiogenesis and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on May 1st, 2012
    This triple analysis focuses on cancer drug development strategies in Pancreatic Cancer and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Learn More

  42. Triple Analysis: Pancreatic Cancer, Angiogenesis and Peptides

    $3,450.00
    Published by BioSeeker Group on Jan 7th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Pancreatic Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Peptides). Learn More

  43. Triple Analysis: Pancreatic Cancer, Angiogenesis and Cancer Vaccines

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in Pancreatic Cancer and by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines. Learn More

  44. Triple Analysis: Pancreatic Cancer, Angiogenesis and Antibodies

    $3,450.00
    Published by BioSeeker Group on Nov 1st, 2012
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Pancreatic Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Antibodies). Learn More

  45. Triple Analysis: Melanoma, Protein Kinase Inhibitors and Peptides

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Peptides). Learn More

  46. Triple Analysis: Melanoma, Protein Kinase Inhibitors and Antibodies

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Antibodies). Learn More

  47. Triple Analysis: Melanoma, Prostate Cancer and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More

  48. Triple Analysis: Melanoma, Prostate Cancer and Peptides

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the compound strategy of Peptides. Learn More

  49. Triple Analysis: Melanoma, Prostate Cancer and Cancer Vaccines

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the mechanism/target/effect of Cancer Vaccines. Learn More

  50. Triple Analysis: Melanoma, Prostate Cancer and Apoptosis

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the mechanism/target/effect of Apoptosis. Learn More

  51. Triple Analysis: Melanoma, Prostate Cancer and Antibodies

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the compound strategy of Antibodies. Learn More

  52. Triple Analysis: Melanoma, Prostate Cancer and Angiogenesis

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the mechanism/target/effect of Angiogenesis. Learn More

  53. Triple Analysis: Melanoma, Pancreatic Cancer and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Melanoma and Pancreatic Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More

  54. Triple Analysis: Melanoma, Pancreatic Cancer and Prostate Cancer

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in Melanoma, Pancreatic Cancer and Prostate Cancer. Learn More

  55. Triple Analysis: Melanoma, Pancreatic Cancer and Peptides

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Melanoma and Pancreatic Cancer and by the compound strategy of Peptides. Learn More

  56. Triple Analysis: Melanoma, Pancreatic Cancer and Cancer Vaccines

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Melanoma and Pancreatic Cancer and by the mechanism/target/effect of Cancer Vaccines. Learn More

  57. Triple Analysis: Melanoma, Pancreatic Cancer and Apoptosis

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Melanoma and Pancreatic Cancer and by the mechanism/target/effect of Apoptosis. Learn More

  58. Triple Analysis: Melanoma, Pancreatic Cancer and Antibodies

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Melanoma and Pancreatic Cancer and by the compound strategy of Antibodies. Learn More

  59. Triple Analysis: Melanoma, Pancreatic Cancer and Angiogenesis

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Melanoma and Pancreatic Cancer and by the mechanism/target/effect of Angiogenesis. Learn More

  60. Triple Analysis: Melanoma, Cancer Vaccines and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors. Learn More

  61. Triple Analysis: Melanoma, Cancer Vaccines and Peptides

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Peptides). Learn More

  62. Triple Analysis: Melanoma, Cancer Vaccines and Antibodies

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Antibodies). Learn More

  63. Triple Analysis: Melanoma, Apoptosis and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Learn More

  64. Triple Analysis: Melanoma, Apoptosis and Peptides

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Apoptosis) and one compound specific area (Peptides). Learn More

  65. Triple Analysis: Melanoma, Apoptosis and Cancer Vaccines

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Apoptosis and Cancer Vaccines. Learn More

  66. Triple Analysis: Melanoma, Apoptosis and Antibodies

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Apoptosis) and one compound specific area (Antibodies). Learn More

  67. Triple Analysis: Melanoma, Apoptosis and Angiogenesis

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Apoptosis and Angiogenesis. Learn More

  68. Triple Analysis: Melanoma, Antibodies and Peptides

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in Melanoma and by the two compound strategies of Antibodies and Peptides. Learn More

  69. Triple Analysis: Melanoma, Angiogenesis and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Learn More

  70. Triple Analysis: Melanoma, Angiogenesis and Peptides

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Peptides). Learn More

  71. Triple Analysis: Melanoma, Angiogenesis and Cancer Vaccines

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines. Learn More

  72. Triple Analysis: Melanoma, Angiogenesis and Antibodies

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Antibodies). Learn More

  73. Triple Analysis: Lymphoma, Protein Kinase Inhibitors and Peptides

    $3,450.00
    Published by BioSeeker Group on Jan 7th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Peptides). Learn More

  74. Triple Analysis: Lymphoma, Protein Kinase Inhibitors and Antibodies

    $3,450.00
    Published by BioSeeker Group on Nov 1st, 2012
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Antibodies). Learn More

  75. Triple Analysis: Lymphoma, Prostate Cancer and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on Sep 12th, 2012
    This triple analysis focuses on cancer drug development strategies in both Lymphoma and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More

  76. Triple Analysis: Lymphoma, Prostate Cancer and Peptides

    $3,450.00
    Published by BioSeeker Group on Jan 7th, 2013
    This triple analysis focuses on cancer drug development strategies in both Lymphoma and Prostate Cancer and by the compound strategy of Peptides. Learn More

  77. Triple Analysis: Lymphoma, Prostate Cancer and Cancer Vaccines

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in both Lymphoma and Prostate Cancer and by the mechanism/target/effect of Cancer Vaccines. Learn More

  78. Triple Analysis: Lymphoma, Prostate Cancer and Apoptosis

    $3,450.00
    Published by BioSeeker Group on Sep 12th, 2012
    This triple analysis focuses on cancer drug development strategies in both Lymphoma and Prostate Cancer and by the mechanism/target/effect of Apoptosis. Learn More

  79. Triple Analysis: Lymphoma, Prostate Cancer and Antibodies

    $3,450.00
    Published by BioSeeker Group on Nov 1st, 2012
    This triple analysis focuses on cancer drug development strategies in both Lymphoma and Prostate Cancer and by the compound strategy of Antibodies. Learn More

  80. Triple Analysis: Lymphoma, Prostate Cancer and Angiogenesis

    $3,450.00
    Published by BioSeeker Group on Sep 12th, 2012
    This triple analysis focuses on cancer drug development strategies in both Lymphoma and Prostate Cancer and by the mechanism/target/effect of Angiogenesis. Learn More

  81. Triple Analysis: Lymphoma, Pancreatic Cancer and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on May 1st, 2012
    This triple analysis focuses on cancer drug development strategies in both Lymphoma and Pancreatic Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More

  82. Triple Analysis: Lymphoma, Pancreatic Cancer and Prostate Cancer

    $3,450.00
    Published by BioSeeker Group on Sep 12th, 2012
    This triple analysis focuses on cancer drug development strategies in Lymphoma, Pancreatic Cancer and Prostate Cancer. Learn More

  83. Triple Analysis: Lymphoma, Pancreatic Cancer and Peptides

    $3,450.00
    Published by BioSeeker Group on Jan 7th, 2013
    This triple analysis focuses on cancer drug development strategies in both Lymphoma and Pancreatic Cancer and by the compound strategy of Peptides. Learn More

  84. Triple Analysis: Lymphoma, Pancreatic Cancer and Cancer Vaccines

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in both Lymphoma and Pancreatic Cancer and by the mechanism/target/effect of Cancer Vaccines. Learn More

  85. Triple Analysis: Lymphoma, Pancreatic Cancer and Apoptosis

    $3,450.00
    Published by BioSeeker Group on Mar 1st, 2012
    This triple analysis focuses on cancer drug development strategies in both Lymphoma and Pancreatic Cancer and by the mechanism/target/effect of Apoptosis. Learn More

  86. Triple Analysis: Lymphoma, Pancreatic Cancer and Antibodies

    $3,450.00
    Published by BioSeeker Group on Nov 1st, 2012
    This triple analysis focuses on cancer drug development strategies in both Lymphoma and Pancreatic Cancer and by the compound strategy of Antibodies. Learn More

  87. Triple Analysis: Lymphoma, Pancreatic Cancer and Angiogenesis

    $3,450.00
    Published by BioSeeker Group on Mar 1st, 2012
    This triple analysis focuses on cancer drug development strategies in both Lymphoma and Pancreatic Cancer and by the mechanism/target/effect of Angiogenesis. Learn More

  88. Triple Analysis: Lymphoma, Melanoma and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More

  89. Triple Analysis: Lymphoma, Melanoma and Prostate Cancer

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in Lymphoma, Melanoma and Prostate Cancer. Learn More

  90. Triple Analysis: Lymphoma, Melanoma and Peptides

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the compound strategy of Peptides. Learn More

  91. Triple Analysis: Lymphoma, Melanoma and Pancreatic Cancer

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in Lymphoma, Melanoma and Pancreatic Cancer. Learn More

  92. Triple Analysis: Lymphoma, Melanoma and Cancer Vaccines

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect of Cancer Vaccines. Learn More

  93. Triple Analysis: Lymphoma, Melanoma and Apoptosis

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect of Apoptosis. Learn More

  94. Triple Analysis: Lymphoma, Melanoma and Antibodies

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the compound strategy of Antibodies. Learn More

  95. Triple Analysis: Lymphoma, Melanoma and Angiogenesis

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect of Angiogenesis. Learn More

  96. Triple Analysis: Lymphoma, Cancer Vaccines and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in Lymphoma and by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors. Learn More

  97. Triple Analysis: Lymphoma, Cancer Vaccines and Peptides

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Peptides). Learn More

  98. Triple Analysis: Lymphoma, Cancer Vaccines and Antibodies

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Antibodies). Learn More

  99. Triple Analysis: Lymphoma, Apoptosis and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on May 1st, 2012
    This triple analysis focuses on cancer drug development strategies in Lymphoma and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Learn More

  100. Triple Analysis: Lymphoma, Apoptosis and Peptides

    $3,450.00
    Published by BioSeeker Group on Jan 7th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect area (Apoptosis) and one compound specific area (Peptides). Learn More

  101. Triple Analysis: Lymphoma, Apoptosis and Cancer Vaccines

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in Lymphoma and by the two mechanism/target/effect areas of Apoptosis and Cancer Vaccines. Learn More

  102. Triple Analysis: Lymphoma, Apoptosis and Antibodies

    $3,450.00
    Published by BioSeeker Group on Nov 1st, 2012
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect area (Apoptosis) and one compound specific area (Antibodies). Learn More

  103. Triple Analysis: Lymphoma, Apoptosis and Angiogenesis

    $3,450.00
    Published by BioSeeker Group on Jan 30th, 2012
    This triple analysis focuses on cancer drug development strategies in Lymphoma and by the two mechanism/target/effect areas of Apoptosis and Angiogenesis. Learn More

  104. Triple Analysis: Lymphoma, Antibodies and Peptides

    $3,450.00
    Published by BioSeeker Group on Jan 7th, 2013
    This triple analysis focuses on cancer drug development strategies in Lymphoma and by the two compound strategies of Antibodies and Peptides. Learn More

  105. Triple Analysis: Lymphoma, Angiogenesis and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on May 1st, 2012
    This triple analysis focuses on cancer drug development strategies in Lymphoma and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Learn More

  106. Triple Analysis: Lymphoma, Angiogenesis and Peptides

    $3,450.00
    Published by BioSeeker Group on Jan 7th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Peptides). Learn More

  107. Triple Analysis: Lymphoma, Angiogenesis and Cancer Vaccines

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in Lymphoma and by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines. Learn More

  108. Triple Analysis: Lymphoma, Angiogenesis and Antibodies

    $3,450.00
    Published by BioSeeker Group on Nov 1st, 2012
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Antibodies). Learn More

  109. Triple Analysis: Lung Cancer, Protein Kinase Inhibitors and Peptides

    $3,450.00
    Published by BioSeeker Group on Jan 7th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lung Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Peptides). Learn More

  110. Triple Analysis: Lung Cancer, Protein Kinase Inhibitors and Antibodies

    $3,450.00
    Published by BioSeeker Group on Nov 1st, 2012
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lung Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Antibodies). Learn More

  111. Triple Analysis: Lung Cancer, Prostate Cancer and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on Sep 12th, 2012
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More

  112. Triple Analysis: Lung Cancer, Prostate Cancer and Peptides

    $3,450.00
    Published by BioSeeker Group on Jan 7th, 2013
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the compound strategy of Peptides. Learn More

  113. Triple Analysis: Lung Cancer, Prostate Cancer and Cancer Vaccines

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the mechanism/target/effect of Cancer Vaccines. Learn More

  114. Triple Analysis: Lung Cancer, Prostate Cancer and Apoptosis

    $3,450.00
    Published by BioSeeker Group on Sep 12th, 2012
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the mechanism/target/effect of Apoptosis. Learn More

  115. Triple Analysis: Lung Cancer, Prostate Cancer and Antibodies

    $3,450.00
    Published by BioSeeker Group on Nov 1st, 2012
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the compound strategy of Antibodies. Learn More

  116. Triple Analysis: Lung Cancer, Prostate Cancer and Angiogenesis

    $3,450.00
    Published by BioSeeker Group on Sep 12th, 2012
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the mechanism/target/effect of Angiogenesis. Learn More

  117. Triple Analysis: Lung Cancer, Pancreatic Cancer and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on May 1st, 2012
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Pancreatic Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More

  118. Triple Analysis: Lung Cancer, Pancreatic Cancer and Prostate Cancer

    $3,450.00
    Published by BioSeeker Group on Sep 12th, 2012
    This triple analysis focuses on cancer drug development strategies in Lung Cancer, Pancreatic Cancer and Prostate Cancer. Learn More

  119. Triple Analysis: Lung Cancer, Pancreatic Cancer and Peptides

    $3,450.00
    Published by BioSeeker Group on Jan 7th, 2013
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Pancreatic Cancer and by the compound strategy of Peptides. Learn More

  120. Triple Analysis: Lung Cancer, Pancreatic Cancer and Cancer Vaccines

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Pancreatic Cancer and by the mechanism/target/effect of Cancer Vaccines. Learn More

  121. Triple Analysis: Lung Cancer, Pancreatic Cancer and Apoptosis

    $3,450.00
    Published by BioSeeker Group on Mar 1st, 2012
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Pancreatic Cancer and by the mechanism/target/effect of Apoptosis. Learn More

  122. Triple Analysis: Lung Cancer, Pancreatic Cancer and Antibodies

    $3,450.00
    Published by BioSeeker Group on Nov 1st, 2012
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Pancreatic Cancer and by the compound strategy of Antibodies. Learn More

  123. Triple Analysis: Lung Cancer, Pancreatic Cancer and Angiogenesis

    $3,450.00
    Published by BioSeeker Group on Mar 1st, 2012
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Pancreatic Cancer and by the mechanism/target/effect of Angiogenesis. Learn More

  124. Triple Analysis: Lung Cancer, Melanoma and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More

  125. Triple Analysis: Lung Cancer, Melanoma and Prostate Cancer

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in Lung Cancer, Melanoma and Prostate Cancer. Learn More

  126. Triple Analysis: Lung Cancer, Melanoma and Peptides

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the compound strategy of Peptides. Learn More

  127. Triple Analysis: Lung Cancer, Melanoma and Pancreatic Cancer

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in Lung Cancer, Melanoma and Pancreatic Cancer. Learn More

  128. Triple Analysis: Lung Cancer, Melanoma and Cancer Vaccines

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the mechanism/target/effect of Cancer Vaccines. Learn More

  129. Triple Analysis: Lung Cancer, Melanoma and Apoptosis

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the mechanism/target/effect of Apoptosis. Learn More

  130. Triple Analysis: Lung Cancer, Melanoma and Antibodies

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the compound strategy of Antibodies. Learn More

  131. Triple Analysis: Lung Cancer, Melanoma and Angiogenesis

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the mechanism/target/effect of Angiogenesis. Learn More

  132. Triple Analysis: Lung Cancer, Lymphoma and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on May 1st, 2012
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Lymphoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More

  133. Triple Analysis: Lung Cancer, Lymphoma and Prostate Cancer

    $3,450.00
    Published by BioSeeker Group on Sep 12th, 2012
    This triple analysis focuses on cancer drug development strategies in Lung Cancer, Lymphoma and Prostate Cancer. Learn More

  134. Triple Analysis: Lung Cancer, Lymphoma and Peptides

    $3,450.00
    Published by BioSeeker Group on Jan 7th, 2013
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Lymphoma and by the compound strategy of Peptides. Learn More

  135. Triple Analysis: Lung Cancer, Lymphoma and Pancreatic Cancer

    $3,450.00
    Published by BioSeeker Group on Mar 1st, 2012
    This triple analysis focuses on cancer drug development strategies in Lung Cancer, Lymphoma and Pancreatic Cancer. Learn More

  136. Triple Analysis: Lung Cancer, Lymphoma and Melanoma

    $3,450.00
    Published by BioSeeker Group on Jun 12th, 2013
    This triple analysis focuses on cancer drug development strategies in Lung Cancer, Lymphoma and Melanoma. Learn More

  137. Triple Analysis: Lung Cancer, Lymphoma and Cancer Vaccines

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Lymphoma and by the mechanism/target/effect of Cancer Vaccines. Learn More

  138. Triple Analysis: Lung Cancer, Lymphoma and Apoptosis

    $3,450.00
    Published by BioSeeker Group on Dec 19th, 2011
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Lymphoma and by the mechanism/target/effect of Apoptosis. Learn More

  139. Triple Analysis: Lung Cancer, Lymphoma and Antibodies

    $3,450.00
    Published by BioSeeker Group on Nov 1st, 2012
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Lymphoma and by the compound strategy of Antibodies. Learn More

  140. Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis

    $3,450.00
    Published by BioSeeker Group on Jan 30th, 2012
    This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Lymphoma and by the mechanism/target/effect of Angiogenesis. Learn More

  141. Triple Analysis: Lung Cancer, Cancer Vaccines and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in Lung Cancer and by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors. Learn More

  142. Triple Analysis: Lung Cancer, Cancer Vaccines and Peptides

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lung Cancer), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Peptides). Learn More

  143. Triple Analysis: Lung Cancer, Cancer Vaccines and Antibodies

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lung Cancer), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Antibodies). Learn More

  144. Triple Analysis: Lung Cancer, Apoptosis and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on May 1st, 2012
    This triple analysis focuses on cancer drug development strategies in Lung Cancer and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Learn More

  145. Triple Analysis: Lung Cancer, Apoptosis and Peptides

    $3,450.00
    Published by BioSeeker Group on Jan 7th, 2013
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lung Cancer), one mechanism/target/effect area (Apoptosis) and one compound specific area (Peptides). Learn More

  146. Triple Analysis: Lung Cancer, Apoptosis and Cancer Vaccines

    $3,450.00
    Published by BioSeeker Group on Mar 19th, 2013
    This triple analysis focuses on cancer drug development strategies in Lung Cancer and by the two mechanism/target/effect areas of Apoptosis and Cancer Vaccines. Learn More

  147. Triple Analysis: Lung Cancer, Apoptosis and Antibodies

    $3,450.00
    Published by BioSeeker Group on Nov 1st, 2012
    This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lung Cancer), one mechanism/target/effect area (Apoptosis) and one compound specific area (Antibodies). Learn More

  148. Triple Analysis: Lung Cancer, Apoptosis and Angiogenesis

    $3,450.00
    Published by BioSeeker Group on Jan 30th, 2012
    This triple analysis focuses on cancer drug development strategies in Lung Cancer and by the two mechanism/target/effect areas of Apoptosis and Angiogenesis. Learn More

  149. Triple Analysis: Lung Cancer, Antibodies and Peptides

    $3,450.00
    Published by BioSeeker Group on Jan 7th, 2013
    This triple analysis focuses on cancer drug development strategies in Lung Cancer and by the two compound strategies of Antibodies and Peptides. Learn More

  150. Triple Analysis: Lung Cancer, Angiogenesis and Protein Kinase Inhibitors

    $3,450.00
    Published by BioSeeker Group on May 1st, 2012
    This triple analysis focuses on cancer drug development strategies in Lung Cancer and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Learn More

Items 1 to 150 of 621 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Ascending Direction